Cargando…
Carotid intima-media thickness in individuals with and without type 2 diabetes: a reproducibility study
BACKGROUND: The use of carotid intima-media thickness (carotid IMT) as a surrogate marker of cardiovascular disease is increasing and the method has now also been applied in several trials investigating patients with type 2 diabetes (T2D). Even though knowledge about methodology is of highest import...
Autores principales: | Lundby-Christensen, Louise, Almdal, Thomas P, Carstensen, Bendix, Tarnow, Lise, Wiinberg, Niels |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931499/ https://www.ncbi.nlm.nih.gov/pubmed/20727128 http://dx.doi.org/10.1186/1475-2840-9-40 |
Ejemplares similares
-
Vitamin D, carotid intima–media thickness and bone structure in patients with type 2 diabetes
por: Winckler, Karoline, et al.
Publicado: (2015) -
Effects of biphasic, basal-bolus or basal insulin analogue treatments on carotid intima-media thickness in patients with type 2 diabetes mellitus: the randomised Copenhagen Insulin and Metformin Therapy (CIMT) trial
por: Lundby-Christensen, Louise, et al.
Publicado: (2016) -
Carotid Intima–Media Roughness and Elasticity in Hypertensive Patients With Normal Carotid Intima‐Media Thickness
por: Wu, Yu, et al.
Publicado: (2018) -
Carotid intima-media thickness in patients with psoriasis with and without metabolic syndrome
por: Ramírez-Terán, Ana L., et al.
Publicado: (2022) -
Metformin may adversely affect orthostatic blood pressure recovery in patients with type 2 diabetes: substudy from the placebo-controlled Copenhagen Insulin and Metformin Therapy (CIMT) trial
por: Hansen, Christian Stevns, et al.
Publicado: (2020)